538 related articles for article (PubMed ID: 19539096)
1. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
Mukai Y; Tampi RR
Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
Reddy S; Kane C; Pitrosky B; Musgnung J; Ninan PT; Guico-Pabia CJ
Curr Med Res Opin; 2010 Jan; 26(1):139-50. PubMed ID: 19919295
[TBL] [Abstract][Full Text] [Related]
3. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
Machado M; Iskedjian M; Ruiz I; Einarson TR
Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
Hirschfeld RM
J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants versus placebo for depression in primary care.
Arroll B; Elley CR; Fishman T; Goodyear-Smith FA; Kenealy T; Blashki G; Kerse N; Macgillivray S
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007954. PubMed ID: 19588448
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant versus placebo for depressed elderly.
Wilson K; Mottram P; Sivanranthan A; Nightingale A
Cochrane Database Syst Rev; 2001; 2001(2):CD000561. PubMed ID: 11405969
[TBL] [Abstract][Full Text] [Related]
8. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
Taylor WD; Doraiswamy PM
Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391
[TBL] [Abstract][Full Text] [Related]
10. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001851. PubMed ID: 17636689
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for depressed elderly.
Mottram P; Wilson K; Strobl J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003491. PubMed ID: 16437456
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
13. Milnacipran and selective serotonin reuptake inhibitors in major depression.
Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Zhang Y; Becker T; Ma Y; Koesters M
BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.
Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA
Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
18. Meta-analytical studies on new antidepressants.
Anderson IM
Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?
Shelton CI
J Clin Psychiatry; 2004; 65 Suppl 17():29-33. PubMed ID: 15600379
[TBL] [Abstract][Full Text] [Related]
20. The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary: cost-effectiveness and budget-impact analyses.
Machado M; Iskedjian M; Ruiz IA; Einarson TR
Pharmacoeconomics; 2007; 25(11):979-90. PubMed ID: 17960955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
